Drawing for SYNTHORX

USPTO serial 88505851

SYNTHORX

Reviewed by CopyMark Law Group

Reg. 6974848Status 700Registered
Filing date
Status date
Registration date
Feb 7, 2023
Examiner
LAMONT, JOHN CHRISTOPHER
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SYNTHORX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexandra Kochian

Alexandra Kochian Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd Street, 17th FloorNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
042medical research; scientific research in the field of DNA; pharmaceutical research and development; laboratory research services in the field of pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, geriatrics, genetics and phenomics, pathology, proteomics, and veterinary medicine and diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agentsACTIVENov 9, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 17, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 2, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Dec 2, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 2, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 2, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 2, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 2, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 7, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 7, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 5, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 4, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Dec 7, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 1, 2022IUAFUSE AMENDMENT FILED—
Dec 1, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 8, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 7, 2022EX5GSOU EXTENSION 5 GRANTED—
Jun 7, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 1, 2022EXT5SOU EXTENSION 5 FILED—
Jun 1, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 12, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 10, 2021EX4GSOU EXTENSION 4 GRANTED—
Nov 10, 2021EXT4SOU EXTENSION 4 FILED—
Nov 10, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 7, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 5, 2021EX3GSOU EXTENSION 3 GRANTED—
May 5, 2021EXT3SOU EXTENSION 3 FILED—
May 5, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 5, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 3, 2020EX2GSOU EXTENSION 2 GRANTED—
Nov 3, 2020EXT2SOU EXTENSION 2 FILED—
Nov 3, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 11, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 9, 2020EX1GSOU EXTENSION 1 GRANTED—
Jun 9, 2020EXT1SOU EXTENSION 1 FILED—
Jun 9, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 10, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 10, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 7, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 7, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 31, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 5, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 5, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 16, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 26, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 25, 2019DOCKASSIGNED TO EXAMINER—
Jul 18, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 17, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 12, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance